BIGG

2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) guideline for the treatment of interstitial lung disease in people with systemic autoimmune rheumatic diseases

Johnson, Sindhu R; Bernstein, Elana J; Bolster, Marcy B; Chung, Jonathan H; Danoff, Sonye K; George, Michael D; Khanna, Dinesh; Guyatt, Gordon; Mirza, Reza D; Aggarwal, Rohit; Allen Jr, Aberdeen; Assassi, Shervin; Buckley, Lenore; Chami, Hassan A; Corwin, Douglas S; Dellaripa, Paul F; Domsic, Robyn T; Doyle, Tracy J; Falardeau, Catherine Marie; Frech, Tracy M; Gibbons, Fiona K; Hinchcliff, Monique; Johnson, Cheilonda; Kanne, Jeffrey P; Kim, John S; Lim, Sian Yik; Matson, Scott; McMahan, Zsuzsanna H; Merck, Samantha J; Nesbitt, Kiana; Scholand, Mary Beth; Shapiro, Lee; Sharkey, Christine D; Summer, Ross; Varga, John; Warrier, Anil; Agarwal, Sandeep K; Antin-Ozerkis, Danielle; Bemiss, Bradford; Chowdhary, Vaidehi; Dematte D’Amico, Jane E; Hallowell, Robert; Hinze, Alicia M; Injean, Patil A; Jiwrajka, Nikhil; Joerns, Elena K; Lee, Joyce S; Makol, Ashima; McDermott, Gregory C; Natalini, Jake G; Oldham, Justin M; Saygin, Didem; Showalter Lakin, Kimberly; Singh, Namrata; Solomon, Joshua J; Sparks, Jeffrey A; Turgunbaev, Marat; Vaseer, Samera; Turner, Amy; Uhl, Stacey; Ivlev, Ilya.

Arthritis rheum; 76 (8), 2024

We provide evidence-based recommendations regarding the treatment of interstitial lung disease (ILD) in adults with systemic autoimmune rheumatic diseases (SARDs). We developed clinically relevant population, intervention, comparator, and outcomes questions. A systematic literature review was then perfor...

Lung Diseases, Interstitial/complications, Rheumatic Diseases/drug therapy, Antirheumatic Agents/therapeutic use, Glucocorticoids/adverse effects

Fulltext